$MBRX METABASIS THERAPEUTICS INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in METABASIS THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in METABASIS THERAPEUTICS INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
METABASIS THERAPEUTICS INC Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
Baracchini Edgardo Jr | Senior VP, Bus. Development | 0 | 0 | May 19 2005 | |||
Baracchini Edgardo Jr | Sr. VP of Business Development | 3,012 | 5,422 | Feb 02 2009 | |||
Baracchini Edgardo Jr | Sr. VP, Business Development | 892 | 1,606 | Jun 28 2006 | |||
Beck John W | Senior VP, Finance & CFO | 0 | 0 | May 19 2005 | |||
Beck John W | Chief Financial Officer | 236,234 | 425,221 | Apr 03 2008 | |||
Beck John W | Sr. VP, Finance & CFO | 9,345 | 16,821 | Nov 13 2006 | |||
BURGESS DANIEL D | Director | 0 | 0 | Jul 30 2004 | |||
BURGESS DANIEL D | Director | 0 | 0 | May 19 2005 | |||
BURGESS DANIEL D | Director | 0 | 0 | May 11 2006 | |||
BURGESS DANIEL D | Director | 0 | 0 | Jun 24 2009 | |||
CASH HARVEY B | 10% Owner | 50,000 | 90,000 | May 24 2006 | |||
CREDIT SUISSE/ | 10% Owner | 3,547,335 | 6,385,203 | Nov 07 2006 | |||
CREDIT SUISSE/ | 10% Owner | 3,863,422 | 6,954,160 | Apr 18 2008 | |||
CREDIT SUISSE/ | 10% Owner | 1,987,030 | 3,576,654 | Oct 04 2005 | |||
CREDIT SUISSE FIRST BOSTON/ | 10% Owner | 514,404 | 925,927 | Jun 23 2004 | |||
Erion Mark D | Chief Executive Officer | 0 | 0 | Feb 02 2009 | |||
EVNIN LUKE | Director | 0 | 0 | Jan 29 2010 | |||
EVNIN LUKE | Director | 0 | 0 | May 11 2006 | |||
EVNIN LUKE | Director | 0 | 0 | Jun 05 2007 | |||
EVNIN LUKE | Director | 4,497,978 | 8,096,360 | Oct 04 2005 | |||
Foyt Howard | Vice President | 0 | 0 | Jan 25 2006 | |||
Foyt Howard | VP of Clinical Development | 0 | 0 | Aug 06 2008 | |||
Frost Wayne | VP of Regulatory Affairs & QA | 0 | 0 | Mar 23 2007 | |||
Gschwend Heinz W | Director | 15,985 | 28,773 | Aug 11 2005 | |||
Gschwend Heinz W | Director | 36,812 | 66,262 | Nov 04 2005 | |||
Gschwend Heinz W | Director | 48,676 | 87,617 | Jun 08 2006 | |||
Gumbiner Barry | VP Clinical Development & CMO | 0 | 0 | Feb 02 2009 | |||
HALE DAVID F | Director | 14,140 | 25,452 | May 19 2005 | |||
HALE DAVID F | Director | 0 | 0 | Nov 09 2006 | |||
HALE DAVID F | Director | 60,337 | 108,607 | Jun 25 2009 | |||
INTERWEST PARTNERS VII L P | 10% Owner | 5,941 | 10,694 | Jun 23 2004 | |||
INTERWEST PARTNERS VII L P | 10% Owner | 120,220 | 216,396 | Oct 04 2005 | |||
INTERWEST PARTNERS VII L P | 10% Owner | 177,970 | 320,346 | Apr 18 2008 | |||
Laikind Paul K | Director | 707,220 | 1,272,996 | Jun 25 2009 | |||
Laikind Paul K | President, CEO & Secretary | 697,558 | 1,255,604 | Sep 11 2006 | |||
Millican Trisha | Principal Accounting Officer | 0 | 0 | Feb 02 2009 | |||
MPM BIOVENTURES II QP LP | 10% Owner | 4,497,978 | 8,096,360 | Oct 04 2005 | |||
MPM BIOVENTURES II QP LP | 10% Owner | 0 | 0 | Jan 29 2010 | |||
Nguyen Tran | VP and CFO | 0 | 0 | Mar 02 2009 | |||
ORONSKY ARNOLD L | Director | 0 | 0 | May 11 2006 | |||
ORONSKY ARNOLD L | Director | 0 | 0 | Jun 24 2009 | |||
ORONSKY ARNOLD L | Director | 5,941 | 10,694 | Jun 23 2004 | |||
ORONSKY ARNOLD L | Director | 177,970 | 320,346 | Jun 11 2008 | |||
ORONSKY ARNOLD L | Director | 0 | 0 | May 19 2005 | |||
ROHN WILLIAM R | Director | 0 | 0 | May 11 2006 | |||
ROHN WILLIAM R | Director | 0 | 0 | Jun 24 2009 | |||
ROHN WILLIAM R | Director | 0 | 0 | Dec 03 2004 | |||
ROHN WILLIAM R | Director | 0 | 0 | May 19 2005 | |||
Schreiner George | Director | 0 | 0 | Jun 24 2009 | |||
SICOR INC | 10% Owner | 2,231,296 | 4,016,333 | Apr 11 2005 | |||
Stoner Elizabeth | Director | 0 | 0 | Jun 25 2009 |